Antibody Complementarity-Determining Region Sequence Design using AlphaFold2 and Binding Affinity Prediction Model
Ueki, T.; Ohue, M.
Show abstract
Affinity maturation in the immune response is limited in terms of affinity gain, and natural antibodies often do not have the binding affinity required for therapeutic applications. Therefore, improving the binding affinity of antibodies is essential for developing antibody-based therapeutics. Designing antibodies using experimental methods is expensive in terms of cost and time owing to the large range of complementarity-determining regions to be explored. Recently, computational methods have been developed as low-cost and fast means of designing and redesigning antibodies. This study evaluated the design performance of AlphaFold2 and the binder hallucination, which can predict protein 3D structures with high accuracy even without experimental antibodies, by redesigning antibody sequences to improve the binding affinity of existing antigen-antibody complexes. Therefore, antibody sequences with higher affinity can be designed for antigen-antibody complexes not included in the training data of AlphaFold2, indicating that the proposed method may be effective as an antibody design method.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Binding affinity prediction for protein-ligand complex using deep attention mechanism based on intermolecular interactions 97%
- DISTEMA: distance map-based estimation of single protein model accuracy with attentive 2D convolutional neural network 97%
- Multi-Head Attention-based U-Nets for Predicting Protein Domain Boundaries Using 1D Sequence Features and 2D Distance Maps 96%
Similar papers in this journal
- Cycledesigner Leveraging RFdiffusion and HighFold to Design Cyclic Peptide Binders for Specific Targets 96%
- From Proteins to Ligands: Decoding Deep Learning Methods for Binding Affinity Prediction 95%
- Pred-AHCP: Robust feature selection enabled Sequence Specific Prediction of Anti-Hepatitis C Peptides via Machine Learning 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.